SUDA PHARMACEUTICALS LTD
ASX
AU Flag
SUD

SUD
SUDA PHARMACEUTICALS LTD
AU Flag
ASX
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

SUD Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Biotechnology & Medical Research
Employees: 14
Suda Pharmaceuticals Ltd, formerly Suda Limited, is a drug delivery company, which is engaged in pharmaceutical development of drug delivery technology, and medical devices and consumables distribution. Its segments are Suda, Westcoast Surgical & Medical Supplies (Westcoast), Malaria Research Company (MRC) and Other. The Suda segment is engaged in research and development to create new human pharmaceutical products by combining drugs with delivery technologies. The Westcoast segment is engaged in sales and logistics operation for medical devices and consumables. The MRC segment is pharmaceutical development segment for the treatment of malaria, including ArTiMist project. ArTiMist is a sublingual spray for the treatment of Plasmodium falciparum severe pediatric malaria. Its other pipeline of products includes Zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its development stage products include orals sprays for the treatment of migraine headache and erectile dysfunction.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing TradingView Coins My Support Tickets Get Help Ideas Published Followers Following Private Messages Chat Sign Out